FindTrial
Sign In

Effects of acute administration of Modafinil on cognition and learning in the elderly

Effects of acute modafinil administration on learning conditional relationships and emergence of stimulus equivalence in the elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5x7z9zf
Enrollment
Unknown
Registered
2022-12-28
Start date
2022-10-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged

Interventions

A baseline assessment will be performed and subsequently individuals will be randomly distributed to receive 100mg of modafinil or placebo. One of the groups will start with modafinil (n=24), while th
D02.455.426.559.389.115.550

Sponsors

Faculdade de Medicina de Ribeirão Preto
Lead Sponsor
Universidade Federal de São Carlos
Collaborator

Eligibility

Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals 60 years of age or older; Be available to return for revaluations and have a telephone to contact

Exclusion criteria

Exclusion criteria: Presence of uncontrolled moderate to severe hypertension; Presence of cardiac arrhythmias, according to self-report; Hearing Loss; Use of Benzodiazepine; Use of cholinesterase inhibitors; medical diagnosis of Dementia, according to self-report

Design outcomes

Primary

MeasureTime frame
It is expected to verify the improvement in cognition and learning in the elderly after acute administration of modafinil—

Secondary

MeasureTime frame
No secondary outcomes expected—

Countries

Brazil

Contacts

Public ContactAna Julia Bomfim

Universidade Federal de São Carlos

anaajullia@hotmail.com+55(016)997212482

Outcome results

None listed

Source: REBEC (via WHO ICTRP)